Influence of storage time on stability of routine coagulation parameters (international normalised ratio, activated partial thromboplastin time and fibrinogen) at room temperature
Objectives: Extending the maximum acceptable specimen age for testing/retesting some routine coagulation parameters has many benefits (e.g., reagent evaluation, fibrinogen add-on for disseminated intravascular coagulation, or addressing sample delay during snow in Otago/Southland). This study assess...
Uloženo v:
| Vydáno v: | New Zealand journal of medical laboratory science Ročník 75; číslo 3; s. 177 - 184 |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Auckland, New Zealand
New Zealand Institute of Medical Laboratory Science
01.11.2021
|
| Témata: | |
| ISSN: | 1171-0195 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Objectives: Extending the maximum acceptable specimen age for testing/retesting some routine coagulation parameters has many benefits (e.g., reagent evaluation, fibrinogen add-on for disseminated intravascular coagulation, or addressing sample delay during snow in Otago/Southland). This study assessed such possibility, where stability of international normalised ratio, activated partial thromboplastin time and Fibrinogen results were examined in relation to storage time.
Methods: From each participating individual (50 total), four citrate tubes were collected. A baseline tube was centrifuged and tested for international normalised ratio, activated partial thromboplastin time and fibrinogen at time of arrival. The other three tubes were kept as whole blood. After 24, 48, and 72 hours respectively from time of collection, one tube was taken for centrifuging and tested for international normalised ratio, activated partial thromboplastin time, and fibrinogen. In addition, centrifuged tubes were retested for international normalised ratio and fibrinogen after 24, 48, and 72 hours respectively (centrifuged fibrinogen after 96 hours) from time of collection. All specimens were kept at room temperature.
Results: The mean bias of international normalised ratio, activated partial thromboplastin time, and fibrinogen at after 24h, 48h, and 72h (centrifuged fibrinogen after 96h) were calculated and compared with specific allowable limits of performance. For both centrifuged and uncentrifuged specimens, international normalised ratio variations up to 72h all passed Royal College of Pathologists of Australasia allowable limits of performance (+-0.3); fibrinogen variations up to 72h (centrifuged fibrinogen up to 96h) all passed European Federation of Clinical Chemistry and Laboratory Medicine allowable limits of performance (+-10.7%). Activated partial thromboplastin time had a clear increasing trend, and all of its variations failed the European Federation of Clinical Chemistry and Laboratory Medicine allowable limits of performance (+-2.7%).
Conclusion: Evidence supports extension of maximum acceptable age of uncentrifuged specimens for international normalised ratio and fibrinogen tests to 72h. Changing the maximum allowable age of activated partial thromboplastin time is not recommended. For centrifuged specimens, we can extend maximum acceptable age for international normalised ratio to 72h and fibrinogen to 96h. |
|---|---|
| AbstractList | Objectives: Extending the maximum acceptable specimen age for testing/retesting some routine coagulation parameters has many benefits (e.g., reagent evaluation, fibrinogen add-on for disseminated intravascular coagulation, or addressing sample delay during snow in Otago/Southland). This study assessed such possibility, where stability of international normalised ratio, activated partial thromboplastin time and Fibrinogen results were examined in relation to storage time. Methods: From each participating individual (50 total), four citrate tubes were collected. A baseline tube was centrifuged and tested for international normalised ratio, activated partial thromboplastin time and fibrinogen at time of arrival. The other three tubes were kept as whole blood. After 24, 48, and 72 hours respectively from time of collection, one tube was taken for centrifuging and tested for international normalised ratio, activated partial thromboplastin time, and fibrinogen. In addition, centrifuged tubes were retested for international normalised ratio and fibrinogen after 24, 48, and 72 hours respectively (centrifuged fibrinogen after 96 hours) from time of collection. All specimens were kept at room temperature. Results: The mean bias of international normalised ratio, activated partial thromboplastin time, and fibrinogen at after 24h, 48h, and 72h (centrifuged fibrinogen after 96h) were calculated and compared with specific allowable limits of performance. For both centrifuged and uncentrifuged specimens, international normalised ratio variations up to 72h all passed Royal College of Pathologists of Australasia allowable limits of performance ([+ or -]0.3); fibrinogen variations up to 72h (centrifuged fibrinogen up to 96h) all passed European Federation of Clinical Chemistry and Laboratory Medicine allowable limits of performance ([+ or -]10.7%). Activated partial thromboplastin time had a clear increasing trend, and all of its variations failed the European Federation of Clinical Chemistry and Laboratory Medicine allowable limits of performance ([+ or -]2.7%). Conclusion: Evidence supports extension of maximum acceptable age of uncentrifuged specimens for international normalised ratio and fibrinogen tests to 72h. Changing the maximum allowable age of activated partial thromboplastin time is not recommended. For centrifuged specimens, we can extend maximum acceptable age for international normalised ratio to 72h and fibrinogen to 96h. Key words: International normalised ratio (INR), activated partial thromboplastin time (APTT), Fibrinogen, specimen age, result stability. Objectives: Extending the maximum acceptable specimen age for testing/retesting some routine coagulation parameters has many benefits (e.g., reagent evaluation, fibrinogen add-on for disseminated intravascular coagulation, or addressing sample delay during snow in Otago/Southland). This study assessed such possibility, where stability of international normalised ratio, activated partial thromboplastin time and Fibrinogen results were examined in relation to storage time. Methods: From each participating individual (50 total), four citrate tubes were collected. A baseline tube was centrifuged and tested for international normalised ratio, activated partial thromboplastin time and fibrinogen at time of arrival. The other three tubes were kept as whole blood. After 24, 48, and 72 hours respectively from time of collection, one tube was taken for centrifuging and tested for international normalised ratio, activated partial thromboplastin time, and fibrinogen. In addition, centrifuged tubes were retested for international normalised ratio and fibrinogen after 24, 48, and 72 hours respectively (centrifuged fibrinogen after 96 hours) from time of collection. All specimens were kept at room temperature. Results: The mean bias of international normalised ratio, activated partial thromboplastin time, and fibrinogen at after 24h, 48h, and 72h (centrifuged fibrinogen after 96h) were calculated and compared with specific allowable limits of performance. For both centrifuged and uncentrifuged specimens, international normalised ratio variations up to 72h all passed Royal College of Pathologists of Australasia allowable limits of performance (+-0.3); fibrinogen variations up to 72h (centrifuged fibrinogen up to 96h) all passed European Federation of Clinical Chemistry and Laboratory Medicine allowable limits of performance (+-10.7%). Activated partial thromboplastin time had a clear increasing trend, and all of its variations failed the European Federation of Clinical Chemistry and Laboratory Medicine allowable limits of performance (+-2.7%). Conclusion: Evidence supports extension of maximum acceptable age of uncentrifuged specimens for international normalised ratio and fibrinogen tests to 72h. Changing the maximum allowable age of activated partial thromboplastin time is not recommended. For centrifuged specimens, we can extend maximum acceptable age for international normalised ratio to 72h and fibrinogen to 96h. ABSTRACT Objectives: Extending the maximum acceptable specimen age for testing/retesting some routine coagulation parameters has many benefits (e.g., reagent evaluation, fibrinogen add-on for disseminated intravascular coagulation, or addressing sample delay during snow in Otago/Southland). [...]the original aim of this study was to examine whether we can extend the maximal acceptable time frame of INR testing. [...]the laboratory can only send specimens away after the requested tests are done, resulting in them all being centrifuged. [...]we evaluated the stability of INR from spun citrate tubes over time. [...]the original aim of this study is to examine whether we can extend the maximal acceptable time frame of INR testing. [...]the laboratory can only send specimens away after the requested tests are done, resulting in them all being centrifuged. [...]we evaluated the stability of INR from spun citrate tubes over time. Among those, 24 subjects were on warfarin, one on dabigatran, and 25 subjects not on any anticoagulation. 34 subjects had their whole blood APTT variation measured, and 39 subjects had their whole blood fibrinogen variation measured. Since APTT and fibrinogen tests were not included in this study initially, the amounts of subjects tested were less than total amount of participants. |
| Audience | Academic |
| Author | Richard M Chen Rhonda Lucas Yii Sen Wee |
| Author_xml | – sequence: 1 fullname: Chen, Richard M – sequence: 2 fullname: Wee, Yii Sen – sequence: 3 fullname: Lucas, Rhonda |
| BookMark | eNptkctqHDEQRXthQ_zIPwiySSAT9BhpuiEbY2zHYMgmWTfV6uqOBj0mUnXA3-UftHomEAJGi0K3zr1FSZfNWUwRz5oLIXZiw0Wn3zWXpew53xqlu4vm5TFOfsFokaWJFUoZZmTkQr3HeofBeUfPazOnhVxEZhPMiwdyFThAhoCEubCPLtYajzp4FlMO4F3BkeVV-8zAkvsDVIXqIlcZ-pVTGNLBQ6nJp6kQRza5IbuYZoyfGFAdnAIjDAesSUvG6-Z8Al_w_d961fy8v_tx-23z9P3h8fbmaTNL0dJm0IPkO9F1o-YWWjkIZe1OiM7owVoujGq3okU9Suw6NFpaDlpDbXfamEmqq-bDKfeQ0-8FC_X7tNQNfemlqX6-cv-oGTz2Lk6JMtjgiu1vTLs1Rki1Zn15g6pnxOBs_aPJVf0_w9eTIQdHvU3eo12ftuyBSi94r5Qwx6AjIDSXQqmtWReWRr0C_9egjQ |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2021 New Zealand Institute of Medical Laboratory Science Copyright New Zealand Institute of Medical Laboratory Science Nov 2021 |
| Copyright_xml | – notice: COPYRIGHT 2021 New Zealand Institute of Medical Laboratory Science – notice: Copyright New Zealand Institute of Medical Laboratory Science Nov 2021 |
| DBID | 3V. 7RV 7XB 8FI 8FJ 8FK ABUWG AFKRA AYAGU BENPR CCPQU FYUFA GHDGH KB0 NAPCQ PHGZM PHGZT PKEHL PPXIY PQEST PQQKQ PQUKI PRINS |
| DatabaseName | ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Australia & New Zealand Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) Nursing & Allied Health Database (Alumni Edition) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China |
| DatabaseTitle | ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium Health Research Premium Collection ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Australia & New Zealand Database ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
| DatabaseTitleList | ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EndPage | 184 |
| ExternalDocumentID | A684661232 10.3316/informit.150213346719926 |
| Genre | Original Articles |
| GeographicLocations | New Zealand |
| GeographicLocations_xml | – name: New Zealand |
| GroupedDBID | --- 04C 123 29N 36B 6PF 7RV 8FI 8FJ AAWTL ABUWG ADBBV ADOJX AFKRA AH1 ALMA_UNASSIGNED_HOLDINGS AS1 AYAGU BENPR BKEYQ BMSDO BPHCQ BVXVI CCPQU ECF ECT EIHBH EX3 FYUFA GJPHO IAO IHR INH INR ITC NAPCQ OK1 P2P PHGZM PHGZT PPXIY PQQKQ PROAC UKHRP WOW WQ9 AFFHD 3V. 7XB 8FK PKEHL PQEST PQUKI PRINS |
| ID | FETCH-LOGICAL-g218t-b5b207199d50ca82b13cc711965bcc01638418e5d2e99e652c0a55a9659566f23 |
| IEDL.DBID | 7RV |
| ISSN | 1171-0195 |
| IngestDate | Sun Nov 09 05:48:33 EST 2025 Tue Nov 11 10:36:43 EST 2025 Tue Nov 04 17:26:13 EST 2025 Tue Oct 21 12:59:27 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-g218t-b5b207199d50ca82b13cc711965bcc01638418e5d2e99e652c0a55a9659566f23 |
| Notes | Informit, Melbourne (Vic) New Zealand Journal of Medical Laboratory Science, Vol. 75, No. 3, Nov 2021, 177-184 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| PQID | 2601609566 |
| PQPubID | 1476363 |
| PageCount | 8 |
| ParticipantIDs | proquest_journals_2601609566 gale_infotracmisc_A684661232 gale_infotracacademiconefile_A684661232 rmit_collectionsjats_10_3316_informit_150213346719926 |
| PublicationCentury | 2000 |
| PublicationDate | 20211101 |
| PublicationDateYYYYMMDD | 2021-11-01 |
| PublicationDate_xml | – month: 11 year: 2021 text: 20211101 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Auckland, New Zealand |
| PublicationPlace_xml | – name: Auckland, New Zealand – name: Auckland |
| PublicationTitle | New Zealand journal of medical laboratory science |
| PublicationYear | 2021 |
| Publisher | New Zealand Institute of Medical Laboratory Science |
| Publisher_xml | – name: New Zealand Institute of Medical Laboratory Science |
| SSID | ssj0046359 |
| Score | 2.1764884 |
| Snippet | Objectives: Extending the maximum acceptable specimen age for testing/retesting some routine coagulation parameters has many benefits (e.g., reagent... ABSTRACT Objectives: Extending the maximum acceptable specimen age for testing/retesting some routine coagulation parameters has many benefits (e.g., reagent... |
| SourceID | proquest gale rmit |
| SourceType | Aggregation Database Publisher |
| StartPage | 177 |
| SubjectTerms | Age Anticoagulants Blood Blood coagulation factors Care Coagulation Enzymatic analysis Fibrin Fibrinogen Hematology Medical examination Medical laboratories Patients Reagents Thromboplastin |
| Title | Influence of storage time on stability of routine coagulation parameters (international normalised ratio, activated partial thromboplastin time and fibrinogen) at room temperature |
| URI | http://search.informit.org/doi/10.3316/informit.150213346719926 https://www.proquest.com/docview/2601609566 |
| Volume | 75 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Nursing & Allied Health Database issn: 1171-0195 databaseCode: 7RV dateStart: 20120401 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://search.proquest.com/nahs omitProxy: false ssIdentifier: ssj0046359 providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Australia & New Zealand Database issn: 1171-0195 databaseCode: AYAGU dateStart: 20120401 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://search.proquest.com/anz omitProxy: false ssIdentifier: ssj0046359 providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central issn: 1171-0195 databaseCode: BENPR dateStart: 20120401 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.proquest.com/central omitProxy: false ssIdentifier: ssj0046359 providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB1Bi1AvlE91oVQ-IAESEWsndtYn1KJWIMGqqgD1Fvkr1aLWaTdpJX4Xf5AZxytYDlw4Ro6dSB6P39gz7wG84NaGinNd1E5igGJLXWgRLPHeYjTBbWVs4pn9VM_ns9NTfZwP3PqcVrnyiclR-87RGfnbRH1FrHnq3eVVQapRdLuaJTRuwyYnbIz2XJ98W3niCjdTPYqrUMhMEhJ_u921uvm0pRxt_-_P3Id7GUyy_XH2H8CtEB_C3c_5uvwR_Py4kiBhXcsoDxK9ByM5edZFfB45un9Q47JDC4yBuc6cZUUvRrTgF5Qu07NXiz9PDlkkpHu-6INnyYLeMKqPuEHc6qkXeo1zRgIMF7a7RHiOI49fNdGzlooMYoeG-5qZgRFyZ0SQldmdH8PXo8Mv7z8UWaWhOEN4MBRWWoE4RWsvp87MhOWlczUnpkLr3JTwXsVnQXoRtA5KCjc1UppEZKhUK8onsBG7GHaAeTcrW2G9rL2pqrbUrfJGBRy0VtO29RN4SfPX0NoblsaZXEKAvYnFqtlXiKaIT0ZMYHftTVwzbr15Na9NXrN983tSJyDJKhpaiikhLvbfzdA3GDCVJVfNyGmLLyCaFhjk42ZDWbzq6b-HfQZbgjJiUiXjLmwMy-vwHO64m2HRL_eS6e7B5sHh_PjkF6Oo_0Y |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB1VBQEXvhELBXwAARIRaydx1geEKqDqqtsVQgX1FvyValHXKZtQ1D_FhT_IjJMIlgO3HjhaiR0lGb-Zl8y8AXjMjfEZ5yopbI4ExaQqUcIb0r1FNsFNpk3UmZ0V8_nk8FC934AfQy0MpVUOmBiB2tWWvpG_jNJXpJonX598TahrFP1dHVpodGax58--I2VrXk3f4vt9IsTOu4M3u0nfVSA5QnfWJiY3Av2qUi4fWz0RhqfWFpyU9Yy1Y4pPMj7xuRNeKS9zYcc6z3UU3pOyIqEDhPwLiOOcyF7x4dOA_Bk6b9U1cyGKTi0r_ob5tTr96MJ2rv1vN38drvbBMtvurPsGbPhwEy7t9-kAt-DndGixwuqKUZ4noiNrF0scBxx3GuRndHBV4w4LntlaH_UdyxjJni8pHahhzxZ_fhllgSL540XjHYs75AWj-o9TjMsdzUJUPGbUYGJp6hOkH7hyd1UdHKuoiCLUuDGfM90yYiaMBMB69erb8PFcHtkd2Ax18HeBOTtJK2FcXjidZVWqKum09LhoIcdV5UbwlOylJGxpV9rqvkQCZ5NKV7ktMVokvRwxgq21MxET7PrhwY7KHpOa8rcRjSAnKywJamLCX2i-6LYpkRCmKZdlp9mLJyBbEDxN0ZlSlrK89-9lH8Hl3YP9WTmbzvfuwxVB2T-xanMLNtvVN_8ALtrTdtGsHsZtw-DzeZvqL4AvV50 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9RADLaqLaq48EYsLTAHECARNTNJJpkDQivKwqpl1QOVyinMK9WibtJuQlF_Fzd-HXYeguXArQeO0TwiTezP9sT-DPCUG-NjzlWQ2gQDFBOpQAlviPcWowluYm1antmDdD7Pjo_V4Qb8HGphKK1ywMQWqF1l6Y58t6W-ItY8uVv0aRGHe9M3Z-cBdZCiP61DO41ORPb95XcM3-rXsz381s-EmL779PZD0HcYCE7QtDWBSYxAG6uUS0KrM2F4ZG3KiWXPWBuSrxLzzCdOeKW8TIQNdZLoloRPyoJIDxD-NzMp03AEm5PPk_dHgx2I0ZSrrrULBezUwOJv0F-r2m8N2vTm_3wUt-BG70azSSf3t2HDl3dg62OfKHAXfsyG5iusKhhlgCJusmaxxOcSnzt28ksaXFWoe6VnttInfS8zRoToS0oUqtmLxZ93pqwkH_90UXvHWt15xagy5AI9dkerEC9PGbWeWJrqDAMT3Ll7qy4dK6i8oqxQZV8y3TCKWRhRg_W81vfg6EqO7D6Myqr0D4A5m0WFMC5JnY7jIlKFdFp63DSVYVG4MTwn2ckJdZqVtrovnsDVxN-VTyT6kcSkI8awszYT0cKuDw8ylfdoVee_BWoMCUlkTiDUpgKW9Vfd1DmGilHEZd6x-eIEjCMEjyI0s5S_LB_-e9snsIUSmh_M5vvbcF1QWlBbzrkDo2b1zT-Ca_aiWdSrx70OMfhy1bL6C1q2YZM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+storage+time+on+stability+of+routine+coagulation+parameters+%28international+normalised+ratio%2C+activated+partial+thromboplastin+time+and+fibrinogen%29+at+room+temperature&rft.jtitle=New+Zealand+journal+of+medical+laboratory+science&rft.au=Richard+M+Chen&rft.au=Yii+Sen+Wee&rft.au=Rhonda+Lucas&rft.date=2021-11-01&rft.pub=New+Zealand+Institute+of+Medical+Laboratory+Science&rft.issn=1171-0195&rft.volume=75&rft.issue=3&rft.spage=177&rft.epage=184&rft.externalDBID=n%2Fa&rft.externalDocID=10.3316%2Finformit.150213346719926 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1171-0195&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1171-0195&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1171-0195&client=summon |